These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 1291628)

  • 1. LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads.
    Böhm HJ
    J Comput Aided Mol Des; 1992 Dec; 6(6):593-606. PubMed ID: 1291628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The computer program LUDI: a new method for the de novo design of enzyme inhibitors.
    Böhm HJ
    J Comput Aided Mol Des; 1992 Feb; 6(1):61-78. PubMed ID: 1583540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel computational tool for automated structure-based drug design.
    Böhm HJ
    J Mol Recognit; 1993 Sep; 6(3):131-7. PubMed ID: 8060670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand design package (Ludi--MSI) applied to known inhibitors of the HIV-1 protease. Test of performance.
    Bogacewicz R; Trylska J; Geller M
    Acta Pol Pharm; 2000 Nov; 57 Suppl():25-8. PubMed ID: 11293255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RASSE: a new method for structure-based drug design.
    Luo Z; Wang R; Lai L
    J Chem Inf Comput Sci; 1996; 36(6):1187-94. PubMed ID: 8941995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo design of enzyme inhibitors by Monte Carlo ligand generation.
    Gehlhaar DK; Moerder KE; Zichi D; Sherman CJ; Ogden RC; Freer ST
    J Med Chem; 1995 Feb; 38(3):466-72. PubMed ID: 7853340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRO-LIGAND: an approach to de novo molecular design. 1. Application to the design of organic molecules.
    Clark DE; Frenkel D; Levy SA; Li J; Murray CW; Robson B; Waszkowycz B; Westhead DR
    J Comput Aided Mol Des; 1995 Feb; 9(1):13-32. PubMed ID: 7751867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRO_LIGAND: an approach to de novo molecular design. 6. Flexible fitting in the design of peptides.
    Murray CW; Clark DE; Byrne DG
    J Comput Aided Mol Des; 1995 Oct; 9(5):381-95. PubMed ID: 8594156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of designed ligands by a multiple screening method: application to glycogen phosphorylase inhibitors constructed with a variety of approaches.
    So SS; Karplus M
    J Comput Aided Mol Des; 2001 Jul; 15(7):613-47. PubMed ID: 11688944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer-aided design and activity prediction of leucine aminopeptidase inhibitors.
    Grembecka J; Sokalski WA; Kafarski P
    J Comput Aided Mol Des; 2000 Aug; 14(6):531-44. PubMed ID: 10921770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetic algorithm for structure-based de novo design.
    Pegg SC; Haresco JJ; Kuntz ID
    J Comput Aided Mol Des; 2001 Oct; 15(10):911-33. PubMed ID: 11918076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flexibases: a way to enhance the use of molecular docking methods.
    Kearsley SK; Underwood DJ; Sheridan RP; Miller MD
    J Comput Aided Mol Des; 1994 Oct; 8(5):565-82. PubMed ID: 7876901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FlexE: efficient molecular docking considering protein structure variations.
    Claussen H; Buning C; Rarey M; Lengauer T
    J Mol Biol; 2001 Apr; 308(2):377-95. PubMed ID: 11327774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in structure-based drug design.
    Klebe G
    J Mol Med (Berl); 2000; 78(5):269-81. PubMed ID: 10954199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flexible matching of test ligands to a 3D pharmacophore using a molecular superposition force field: comparison of predicted and experimental conformations of inhibitors of three enzymes.
    McMartin C; Bohacek RS
    J Comput Aided Mol Des; 1995 Jun; 9(3):237-50. PubMed ID: 7561976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BREED: Generating novel inhibitors through hybridization of known ligands. Application to CDK2, p38, and HIV protease.
    Pierce AC; Rao G; Bemis GW
    J Med Chem; 2004 May; 47(11):2768-75. PubMed ID: 15139755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular surface-volume and property matching to superpose flexible dissimilar molecules.
    Perkins TD; Mills JE; Dean PM
    J Comput Aided Mol Des; 1995 Dec; 9(6):479-90. PubMed ID: 8789190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GenStar: a method for de novo drug design.
    Rotstein SH; Murcko MA
    J Comput Aided Mol Des; 1993 Feb; 7(1):23-43. PubMed ID: 8473916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Target Drug Design Using LigBuilder 3.
    Qing X; Wang S; Yuan Y; Pei J; Lai L
    Methods Mol Biol; 2021; 2266():279-298. PubMed ID: 33759133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative structure-activity relationships by distance geometry: systematic analysis of dihydrofolate reductase inhibitors.
    Crippen GM
    J Med Chem; 1980 Jun; 23(6):599-606. PubMed ID: 7392027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.